Treatment Outreach Network 2021 meeting held virtually
NAPWHA’s Treatment Outreach Network – a membership of professionals from Australian State and Territory peer-based organisations and AIDS Councils, held their annual formal meeting via video conferencing in April and November 2021. The Treatment Outreach Network 2020 meeting was also held online during COVID-19 restrictions.
Treatment Outreach Network meeting agenda
|11 – 11.15am||Acknowledgement of Country|
|11.15am – 12.00pm|
Treatments and update from European AiDS Clinical Meeting – Presentation and Q&A
|12.00 – 12.15 pm||Break / 15 minutes|
12.15 – 12.45pm
NAPWHA Research Literacy and Treatment Initiative – Scoping session to identify research literacy needs
|12.45 – 1.15pm|
ARVs and weight gain – Presentation and Q&A
|1.15 – 1.30pm||Meeting review and evaluation|
ARVs and weight gain
In this presentation to the Treatment Outreach Network,
Professor Jennifer Hoy – Director HIV Medicine at
Department of Infectious Diseases, The Alfred, presents a version of
What is known about weight gain on INSTI-based regimens?
In this presentation, Dr Jennifer Hoy makes references to:
- Michael Silverberg et al, “Changes in body mass index over time in persons with and without HIV.” 23rd International AIDS Conference. (2020) Abstract OAB0603.
- Myles Helfand, “Body Mass Index Among People With HIV Is Rising Much Faster Than in the General Population.” TheBody/TheBodyPro (2020)
- Bourgi K. et al., “Greater weight gain among treatment- naïve persons starting integrase inhibitors: NA-ACCORD.” Conference on Retroviruses and Opportunistic Infections (2019). Abstract #670.
- Hill A. et al., “Progressive rises in weight and clinical obesity… ADVANCE and NAMSAL trials.” 22nd International AIDS Conference. (2019) Abstract 4772.
- Mallon P. et al., “Weight gain before and after switch from TDF to TAF in a U.S. cohort study.” J Int AIDS Soc. 2021 Apr; 24(4): e25702.
- Ramgopal M et al. Pooled analysis of 4 international trials of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in adults aged >65 or older demonstrating safety and efficacy: week 48 results. 23rd International AIDS Conference, abstract OAB0403, 2020.
- Liz Highleyman, “Switching to Biktarvy maintains viral suppression in people aged 65 or over.” NAM aidsmap (2020)
- European AIDS Clinical Society, “EACS Guidelines – Version 10.1.” (October 2020) – refer to p. 53 on Dietary Counselling and ART
Additional viewing: Emma Sheldon-Collins, Community Advocate speaking to Dr James McMahon (The Alfred, Victoria) for the HIV ARV Guidelines Session at 2020 Australasian HIV & Sexual Health Conference
About the NAPWHA Treatment Outreach Network
The Treatment Outreach Network (TON) is a formal collaboration of HIV community sector professionals working to optimise the overall wellbeing of People Living with HIV (PLHIV) in Australia, by providing a high standard of information and current research on issues of health and treatments for HIV.
TON’s role is to provide consistent and up-to-date information to HIV sector professionals working at state and territory HIV community organisations as well as PLHIV. NAPWHA maintains a range of partnerships to ensure the aims of the network are met. The network meets formally once per year and informal communication occurs throughout the rest of the year to continue TON’s work.